Eli Lilly is a leader in the weight loss drug market, generating blockbuster revenue. Viking Therapeutics recently launched a phase 3 trial for its weight loss candidate -- and could have a promising ...

The two largest health insurers in Massachusetts are effectively telling the drug companies that they may seek a rapidly ...

Insurers are cutting coverage, citing costs. But there’s seldom any discussion of the return on investment from these drugs ...

Getting into the exercise habit was also important since one day, most people on Ozempic or Wegovy will stop taking it - putting themselves at risk of putting the weight back on if they were not ...

As the use of GLP-1 medications such as Ozempic, Wegovy and Mounjaro becomes more widespread for weight loss, a growing concern is the unintended loss of muscle mass that often accompanies rapid fat ...

GLP-1 drugs like Ozempic® and Zepbound® have gained significant attention for treating both diabetes and assisting with weight loss.

A SLIMMING World Manager from Carlisle says slimming clubs are needed more than ever despite the growing popularity of weight ...

The country’s Medicines and Healthcare products Regulatory Agency’s (MHRA) Yellow Card scheme, the UK’s official system for ...

Migraines are one of the world's most common neurological conditions, impacting nearly 15% of people globally. Despite this ...

Some patients are aiming to lower their BMIs in order to increase their fertility; others are aiming to manage BMI-related ...

Health insurance companies, including CVS Caremark, are altering coverage for GLP-1 weight loss medications like Zepbound, ...